左心房附属体干预的未来
Matteo Casenghi1, Sara Corradetti2, Emiliano Navarra2
1Sant'Andrea Hospital, Rome, Italy - matcasenghi@hotmail.it.
Minerva cardiology and angiology
|June 6, 2024
概括
穿皮左心房尾封闭 (LAAO) 是一种低风险的手术,用于预防心房患者的中风. 需要进一步的研究来优化安全性,有效性和标准化,以便更广泛地采用.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
- 医疗器械 医疗器械
背景情况:
- 穿皮左心房尾闭塞 (LAAO) 是一种新兴的手术,用于预防心房的患者中风.
- 虽然LAAO被认为是相对较低的风险,但需要进一步优化以与较新的口服抗凝剂竞争.
- 挑战包括全面的数据采集,标准化规划和程序简化.
研究的目的:
- 提供对未来提高LAAO安全性和有效性的机会的概述.
- 建立LAAO作为中风和全身栓塞预防的主流战略.
- 为治疗心房的患者和抗凝药物的禁忌.
主要方法:
- 审查LAAO当前的临床实践和挑战.
- 对现有的安全性和疗效数据的分析.
- 讨论程序优化和标准化的潜在策略.
主要成果:
- 在特定患者群体中,LAAO是预防中风的可行,低风险的替代方案.
- 有机会改善数据收集,程序前规划和程序技术.
- 标准化和进一步的证据生成是建立LAAO作为主流治疗的关键.
结论:
- 通过数据采集和标准化提高程序安全性和有效性对LAAO至关重要.
- 作为心房动和抗凝药禁忌患者的初级中风预防策略,LAAO具有显著的潜力.
- 持续的研究和开发是必要的,以充分实现LAAO的好处.
相关概念视频
Cardiac Catheterization III: Left Heart Catheterization
Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
Mitral Regurgitation III: Medical Management
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Aortic Regurgitation III: Medical Management
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...


